What one share of Zimmer Biomet Holdings holds
Zimmer Biomet is a global medical technology leader with a comprehensive portfolio designed to maximize mobility and improve health. We design, manufacture and market orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; craniomaxillofacial and thoracic (“CMFT”) products; bone cement; surgical products; and a suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence.
Zimmer Biomet Holdings’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $43.33 |
|---|---|
| Profit | $4.11 |
| Capex (buildings and equipment) | $1.12 |
| Free cash flow | $7.76 |
| Dividends | $0.96 |
| Cash and investments | $2.15 |
| Debt | $39.24 |
| Book value | $66.23 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2007 | $16.41 | $3.26 | $0.81 | $3.75 | — | $23.15 |
| 2008 | $18.05 | $3.72 | $1.10 | $3.45 | — | $25.27 |
| 2009 | $18.98 | $3.32 | $0.49 | $4.69 | — | $27.61 |
| 2010 | $20.99 | $2.97 | $0.39 | $5.54 | — | $29.51 |
| 2011 | $23.59 | $4.03 | $0.60 | $5.63 | $0.18 | $30.94 |
| 2012 | $25.41 | $4.29 | $0.65 | $5.89 | $0.54 | $34.15 |
| 2013 | $26.91 | $4.54 | $0.58 | $5.02 | $0.80 | $37.09 |
| 2014 | $27.22 | $4.20 | $0.84 | $5.33 | $0.88 | $38.60 |
| 2015 | $31.60 | $0.77 | $0.88 | $3.59 | $0.88 | $48.78 |
| 2016 | $37.89 | $1.51 | $0.91 | $7.15 | $0.96 | $48.20 |
| 2017 | $38.31 | $8.90 | $0.77 | $7.00 | $0.96 | $57.93 |
| 2018 | $38.98 | −$1.86 | $0.80 | $7.79 | $0.96 | $55.25 |
| 2019 | $38.62 | $5.47 | $1.00 | $6.67 | $0.96 | $60.14 |
| 2020 | $29.60 | −$0.67 | $0.54 | $5.28 | $0.96 | $58.74 |
| 2021 | $32.45 | $1.91 | $0.68 | $6.44 | $0.96 | $60.58 |
| 2022 | $33.00 | $1.10 | $0.89 | $5.56 | $0.96 | $57.51 |
| 2023 | $35.26 | $4.88 | $1.39 | $6.15 | $0.96 | $60.70 |
| 2024 | $37.66 | $4.43 | $1.00 | $6.35 | $0.96 | $62.62 |
| 2025 | $41.43 | $3.55 | $1.13 | $7.41 | $0.96 | $64.95 |
Common questions about Zimmer Biomet Holdings
How much does one share of Zimmer Biomet Holdings earn?
Over the last 12 months, each share of Zimmer Biomet Holdings earned $4.11 of profit on $43.33 of sales, keeping about 9¢ of every $1 (profit margin).
Does Zimmer Biomet Holdings pay a dividend?
Yes. Zimmer Biomet Holdings paid $0.96 per share in dividends over the last 12 months, and it paid a dividend in every year from 2011 to 2025 in StockSlicer’s data. That’s about 23¢ of each $1 of profit (payout ratio).
What is Zimmer Biomet Holdings’s book value per share?
Zimmer Biomet Holdings’s book value is $66.23 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of Zimmer Biomet Holdings have?
Each share of Zimmer Biomet Holdings has $2.15 of cash and investments and $39.24 of debt, as of June 30, 2026.
What is Zimmer Biomet Holdings’s free cash flow per share?
$7.76 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.
How has Zimmer Biomet Holdings’s profit per share changed over time?
Profit per share went from $3.26 in 2007 to $3.55 in 2025, growing about 0.5% a year (adjusted for stock splits).
Has Zimmer Biomet Holdings bought back shares?
Zimmer Biomet Holdings’s share count fell about 16% from 2007 to 2025. Through buybacks, each remaining share owns a bigger slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.